CVE-2021-38961 Explained : Impact and Mitigation

IBM OPENBMC OP910 is vulnerable to cross-site scripting, allowing attackers to inject arbitrary JavaScript code into the Web UI. This can potentially lead to altering functionality and disclosing credentials within a trusted session.

Understanding CVE-2021-38961

This section delves into the details of the cross-site scripting vulnerability in IBM OPENBMC OP910.

What is CVE-2021-38961?

CVE-2021-38961 refers to a cross-site scripting vulnerability in IBM OPENBMC OP910 that enables malicious actors to insert malicious JavaScript code into the Web UI.

The Impact of CVE-2021-38961

The impact of this vulnerability is categorized as medium severity. It can potentially allow attackers to manipulate the Web UI's behavior and compromise sensitive information in trusted sessions.

Technical Details of CVE-2021-38961

This section provides more technical insights into the vulnerability.

Vulnerability Description

The vulnerability allows for the injection of arbitrary JavaScript code into the Web UI of IBM OPENBMC OP910.

Affected Systems and Versions

IBM OPENBMC OP910 version is affected by this vulnerability.

Exploitation Mechanism

Exploiting this vulnerability involves injecting malicious JavaScript code into the Web UI, which can then be executed within a trusted session.

Mitigation and Prevention

Here are the recommended steps to address and prevent the exploitation of CVE-2021-38961.

Immediate Steps to Take

Users should update to a patched version of OPENBMC OP910 to mitigate the risk of cross-site scripting attacks.

Long-Term Security Practices

Implementing secure coding practices and regularly updating software can help prevent similar vulnerabilities in the future.

Patching and Updates

Stay informed about security updates and apply patches promptly to protect systems from potential exploits.